Johnson & Johnson
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 88.8B 85.2B 80.0B 78.7B
Cost of revenue 27.5B 26.6B 24.6B 23.4B
Gross profit 61.4B 58.6B 55.4B 55.3B
Operating expense
Research & development 17.2B 15.1B 14.1B 14.3B
Selling general and admin 22.0B 20.1B 20.2B 20.1B
Other operating expenses
Operating income 22.1B 23.4B 21.0B 20.9B
Non operating interest income
Income 1.3B 1.3B 490M 53M
Expense 755M 772M 276M 183M
Other income expense -6.0B -8.8B -1.9B -1.6B
Pretax income 16.7B 15.1B 19.4B 19.2B
Tax provision 2.6B 1.7B 3.0B 1.4B
Net income 14.1B 35.2B 17.9B 20.9B
Basic EPS 5.8 13.9 6.8 7.9
Diluted EPS 5.8 13.7 6.7 7.8
Basic average shares 2.4B 2.5B 2.6B 2.6B
Diluted average shares 2.4B 2.5B 2.6B 2.6B
EBITDA 31.9B 32.3B 27.7B 27.9B
Net income from continuing op. 14.1B 35.2B 17.9B 20.9B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 15 minutes

10:44
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).